ASMB - Assembly Biosciences Inc logo

ASMB

Assembly Biosciences Inc

Rev โ€”top 1%10Y
Hold

Assembly Biosciences develops antiviral therapeutics targeting viral diseases, focusing on chronic infections like hepatitis B and D, and herpesvirus. Its pipeline includes small-molecule candidates in clinical trials to improve patient outcomes globally.

โš•๏ธ Healthcare NASDAQ Listed 2010 $ USD
$1,000 invested 10 years ago โ†’$389today

Score Overview

1 Year
Score
Net Growth-4.26%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-1.67%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score7.0
Net Growth95.08%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth11x
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth85.58%
Net Trend60%
Net Income Consistency
Rev Growthโ€”
Rev Trend70%
Revenue Consistency
All Time
Scoreโ€”
Net Growth58.26%
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev Trend47%
Revenue Consistency

See the full market ranking โ†’

Assembly Biosciences Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 79M to $ 72M and net income went from -$ 62M to -$ 6M. Revenue increased in 3 of those 5 years; net income in 4.

Assembly Biosciences Inc currently holds a 5-year HDB Score of 7.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 27.06โ€”
1 Year2025-08-12
$ 23.9912.80%
5 Years2021-08-12
$ 42.96-37.01%
10 Years2016-08-12
$ 69.60-61.12%
All Time2010-12-17
$ 378.00-92.84%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 71M-$ 6M$ 226M
2025$ 72M-$ 6M$ 248M
2024$ 28M-$ 40M$ 112M
2023$ 7M-$ 61M$ 130M
2022$ 0.00-$ 92M$ 91M
2021$ 6M-$ 129M$ 146M
2020$ 79M-$ 62M$ 216M
2019$ 15M-$ 97M$ 274M
2018$ 14M-$ 90M$ 218M
2017$ 9M-$ 42M$ 119M
2016$ 0.00-$ 44M$ 52M
2015$ 0.00-$ 28M$ 67M
2014$ 0.00-$ 23M$ 29M
2013$ 0.00-$ 19M$ 27M
2012$ 0.00-$ 24M$ 20M
2011$ 0.00-$ 34M$ 36M
IPO2010-$ 15M$ 14M

Explore beyond ASMB

You're looking at Assembly Biosciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies